COVID-19 antibody-binding site is conserved across variants, Penn State biomedical engineers find

Led by Deb Kelly, professor of biomedical engineering (BME), Huck Chair in Molecular Biophysics and director of the Penn State Center for Structural Oncology, a team of biomedical engineers used a novel toolkit of approaches to uncover the first full structure of SARS-CoV-2’s Nucelocapsid protein. When compared to coronavirus variants, the researchers found that the antibody-binding site appears to be the same. The finding could inform advanced treatments and vaccines. Read more: https://news.engr.psu.edu/2021/kelly-...